1-20 of 65 results for subject:Patients
Librarians' tools
- Search time
- 0.24 seconds
- Solr query time
- 0.009 seconds
- Search query
- subject:Patients
- We searched for
- subject_t:Patients OR subject_t:"Sick people" OR subject_ses:92375
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
I welcome the review and the announcement of Baroness Cumberlege as its lead. I am sure the whole House will agree that she is, as the Secretary of State said, highly qualified and trusted. I pay tribute to the many hundreds of thousands of women who have suffered in silence...
I welcome the review and the announcement of Baroness Cumberlege as its lead. I am sure the whole House will agree that she is, as the Secretary of State said, highly qualified and trusted. I pay tribute to the many hundreds of thousands of women who have suffered in silence...
To ask the Secretary of State for Health, whether his Department has assessed the effect on (a) patients and (b) patient choice of centralised procurement.
To ask the Secretary of State for Health, whether his Department has assessed the effect on (a) patients and (b) patient choice of centralised procurement.
‘Centralised procurement’ can sometimes be used to refer to the services of NHS Supply Chain. NHS Supply Chain offers a procurement and logistics service to all National Health Service trusts in the United Kingdom under a central service contract on behalf of NHS Business Services Authority.
There is currently no centralised procurement model mandated to the NHS by the Department, and as such no assessment has been made as to an effect on patients or patient choice. NHS trusts may choose to utilise the service offering of NHS Supply Chain, or choose an alternative. It is for NHS trusts to make their own choices with regard to products and services they purchase; therefore it is for individual trusts to assess any impact on patients and patient choice.
To ask the Secretary of State for Health, how many patients were discharged from hospital between 11pm and 6am in each of the last six years.
To ask the Secretary of State for Health, how many patients were discharged from hospital between 11pm and 6am in each of the last six years.
The information is not held in the format requested.
To ask the Secretary of State for Health, if he will take steps to reduce the cost to the NHS of postage of appointment notifications to patients.
To ask the Secretary of State for Health, if he will take steps to reduce the cost to the NHS of postage of appointment notifications to patients.
The National Information Board’s strategy document Personalised Health and Care 2020 (published November 2014) set out the aim to support greater uptake of the use of digital systems in health and care to create a National Health Service paper free at the point of care by 2020. This will remove the system’s reliance on paper and will help reduce postal service costs for the NHS.
In the case of appointment letters for patients the new NHS e-referral system, introduced last year, already allows healthcare providers to choose not to send out appointment letters, instead allowing patients to access the information directly from the NHS e-referral system. Patients have an option to print off the details of their appointment if they prefer to have a paper copy of the information. We expect increasing numbers of providers will use this functionality to help contain costs.
To ask the Secretary of State for Health, what steps his Department is taking to ensure all patients have the opportunity to participate in clinical trials and research.
To ask the Secretary of State for Health, what steps his Department is taking to ensure all patients have the opportunity to participate in clinical trials and research.
The NHS Constitution includes the following pledge: “The NHS commits to inform you of research studies in which you may be eligible to participate”. The Department, via the National Institute for Health Research (NIHR), has a number of initiatives to deliver on the pledge, including the UK Clinical Trials Gateway (https://www.ukctg.nihr.ac.uk/) which is a public website where patients, carers and clinicians can find out about clinical studies current studies underway.
The NIHR runs an annual national campaign called ‘Ok to ask’, to encourage the public to ask their clinician about research participation; more specifically, in 2014, the NIHR launched Join Dementia Research to encourage 100,000 people to volunteer to participate in dementia research by 2020; finally, through the NIHR Clinical Research Networks, last year 618,000 patients were recruited by NHS Providers into clinical trials.
To ask the Secretary of State for Health, what proportion of patients in England book their GP appointments online.
To ask the Secretary of State for Health, what proportion of patients in England book their GP appointments online.
The latest figures available for November 2015 show 7.97 million patients are registered to enable them to book and cancel appointments online. This represents 13.9% of the general practitioner registered population.
Amendments to clause 1 negatived on division (5 votes to 9). Clause 1, discussed with new clause 1 (Licenses for off-patent drugs) and new clause 2 (Appraisals for off-patent drugs) agreed to. Clauses 2 to 6 agreed to. Bill to be reported, without amendment.
Amendments to clause 1 negatived on division (5 votes to 9). Clause 1, discussed with new clause 1 (Licenses for off-patent drugs) and new clause 2 (Appraisals for off-patent drugs) agreed to. Clauses 2 to 6 agreed to. Bill to be reported, without amendment.
Queen's recommendation signified. Money resolution. Agreed to on division (281 to 227).
Queen's recommendation signified. Money resolution. Agreed to on division (281 to 227).
I beg to move,
That, for the purposes of any Act resulting from the Access to Medical Treatments (Innovation) Bill, it is expedient to authorise the payment out of money provided by Parliament of any increase attributable to the Act in the sums payable under any other Act out of money...
I beg to move,
That, for the purposes of any Act resulting from the Access to Medical Treatments (Innovation) Bill, it is expedient to authorise the payment out of money provided by Parliament of any increase attributable to the Act in the sums payable under any other Act out of money...
The debate on Second Reading raised a large number of issues, which clearly need to be addressed and I have no doubt will be addressed in Committee. We cannot second-guess where that Committee will get to or the shape of any Bill that might subsequently return to the Floor of...
The debate on Second Reading raised a large number of issues, which clearly need to be addressed and I have no doubt will be addressed in Committee. We cannot second-guess where that Committee will get to or the shape of any Bill that might subsequently return to the Floor of...
My hon. Friend makes a good point. That is the premise on which the Bill introduced by Lord Saatchi in the other place earlier in the year in the previous Parliament was predicated. My hon. Friend is right that it is a controversial proposition that fear of litigation for medical...
My hon. Friend makes a good point. That is the premise on which the Bill introduced by Lord Saatchi in the other place earlier in the year in the previous Parliament was predicated. My hon. Friend is right that it is a controversial proposition that fear of litigation for medical...
The hon. Lady makes a series of interesting points. Her criticisms would perhaps apply more to the Bill introduced by Lord Saatchi in the other House. Let me confirm that this Bill has nothing at all to do with clinical research. It is to do with clarifying the freedoms that...
The hon. Lady makes a series of interesting points. Her criticisms would perhaps apply more to the Bill introduced by Lord Saatchi in the other House. Let me confirm that this Bill has nothing at all to do with clinical research. It is to do with clarifying the freedoms that...
I want to make two things absolutely clear. First, this Bill, in law, would have no impact at all on clinical research. We in the Department have been very clear about that. If it in any way changed the basis on which clinical research is regulated, it would be a...
I want to make two things absolutely clear. First, this Bill, in law, would have no impact at all on clinical research. We in the Department have been very clear about that. If it in any way changed the basis on which clinical research is regulated, it would be a...
Yes, indeed; I have listened. I acknowledged those concerns on Second Reading and said I was concerned about them. This is merely a debate about the Bill—there is no change in the law—and it is only this debate that is upsetting people at the moment. It is therefore very important...
Yes, indeed; I have listened. I acknowledged those concerns on Second Reading and said I was concerned about them. This is merely a debate about the Bill—there is no change in the law—and it is only this debate that is upsetting people at the moment. It is therefore very important...
As my hon. Friend knows, I have a lot of respect for his logic and his position, so let me be very clear again. As I tried to explain, I accept that if one were setting out a list of the biggest barriers to the uptake of innovation, fear of...
As my hon. Friend knows, I have a lot of respect for his logic and his position, so let me be very clear again. As I tried to explain, I accept that if one were setting out a list of the biggest barriers to the uptake of innovation, fear of...
The hon. Gentleman will be familiar with the procedures of the House, but I just want to confirm that once the House has given a private Member’s Bill a Second Reading, the convention is that the Government, even when they robustly oppose it, always table a money resolution so that...
The hon. Gentleman will be familiar with the procedures of the House, but I just want to confirm that once the House has given a private Member’s Bill a Second Reading, the convention is that the Government, even when they robustly oppose it, always table a money resolution so that...
It is not for me to defend this private Member’s Bill, promoted by my hon. Friend the Member for Daventry (Chris Heaton-Harris), but I want to deal with two or three points that have been raised in connection with the Government’s view of clinical research and patient safety, both of...
It is not for me to defend this private Member’s Bill, promoted by my hon. Friend the Member for Daventry (Chris Heaton-Harris), but I want to deal with two or three points that have been raised in connection with the Government’s view of clinical research and patient safety, both of...
To ask the Secretary of State for Health, what assessment he has made of the effect of the abolition of the Patient Safety Agency and the transfer of its responsibility for the National Reporting and Learning System to NHS England on the number of patient safety alerts issued between June...
To ask the Secretary of State for Health, what assessment he has made of the effect of the abolition of the Patient Safety Agency and the transfer of its responsibility for the National Reporting and Learning System to NHS England on the number of patient safety alerts issued between June...
Responsibility for issuing patient safety advice to the healthcare system in the form of patient safety alerts transferred from the National Patient Safety Agency to NHS England in June 2012. Between June 2012 – December 2013 one Patient Safety Alert (NHS/PSA/W/2013/001: ‘Placement devices for nasogastric tube insertion DO NOT replace initial position checks’) was issued on 5 December 2013. To date, all providers have reported this alert as either ‘complete’ or ‘action not required’.
During the period in question NHS England maintained a constant review of patient safety incidents reported to the National Reporting and Learning System involving death and severe harm and, had an urgent patient safety issue needing alerting been identified, an alert would have been issued.
To ask the Secretary of State for Health, by what date he plans to start patient communications in care.data pathfinder areas on the implications for patients of that programme to begin.
To ask the Secretary of State for Health, by what date he plans to start patient communications in care.data pathfinder areas on the implications for patients of that programme to begin.
No patient communications will occur until the independent expert Dame Fiona Caldicott, as National Data Guardian, has reviewed them and provided advice.
To ask the Secretary of State for Health, what part consultation and stakeholder engagement will play in NHS England's review of regulations relating to dispensing appliance contractor licences.
To ask the Secretary of State for Health, what part consultation and stakeholder engagement will play in NHS England's review of regulations relating to dispensing appliance contractor licences.
NHS England currently has no plans to ask the Department to consider making any changes in respect of those provisions of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended, that relate to dispensing appliance contractors. If NHS England were to undertake a review of the regulatory arrangements concerning dispensing appliance contractors, it would take account of a range of factors including the views of patients, consumers and business.